Tapewire

Nasdaq · USD

PALI

PALISADE BIO, INC.

Export transactions ↓
Tapewire entity
5803
SEC CIK
0001357459
Parsed reports
182

Last 12 months

Inside the activity.

10 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202620
Feb 202602
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202662
Aug 202600
Sep 202600
Oct 202620

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 06, 2025 Filed Oct 8, 2025 21:41 UTC
Jones Mitchell LawrenceChief Medical Officer
GrantRestricted Stock Units · Derivative 7,665,800 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-017477 · ownership.xml · derivative · entry 1

Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,665,800

Underlying: Common Stock · 7,665,800 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash.

F2 · derivative.exercise_date: The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.

F2 · derivative.expiration_date: The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.

Read SEC document
October 06, 2025 Filed Oct 8, 2025 21:35 UTC
Chuang EmilDirector
GrantRestricted Stock Units · Derivative 510,700 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-017473 · ownership.xml · derivative · entry 1

Chuang Emil · CIK 0001921045 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 510,700

Underlying: Common Stock · 510,700 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash.

F2 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, which shall be satisfied on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date.

F2 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, which shall be satisfied on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date.

Read SEC document
October 06, 2025 Filed Nov 7, 2025 01:21 UTC Amendment GrantRestricted Stock Units · Derivative 182,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-021134 · ownership.xml · derivative · entry 1

Williams Donald Allen · CIK 0001620013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 182,000

Underlying: Common Stock · 182,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan (the "Plan") to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash.

F2 · shares: This amended Form 4 is being filed to correct the previously reported grant amount of 1,538,700 RSUs to the Reporting Person. The Issuer has rescinded the grant of 1,356,700 RSUs of the previously reported grant of 1,538,700 RSUs.

F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date.

F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date.

Read SEC document
October 06, 2025 Filed Nov 7, 2025 01:18 UTC Amendment
Chuang EmilDirector
GrantRestricted Stock Units · Derivative 60,600 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-021132 · ownership.xml · derivative · entry 1

Chuang Emil · CIK 0001921045 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,600

Underlying: Common Stock · 60,600 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan (the "Plan") to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash.

F2 · shares: This amended Form 4 is being filed to correct the previously reported grant amount of 510,700 RSUs to the Reporting Person. The Issuer has rescinded the grant of 450,100 RSUs of the previously reported grant of 510,700 RSUs.

F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date.

F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date.

Read SEC document
October 06, 2025 Filed Nov 7, 2025 01:20 UTC Amendment
Wei BinxianDirector
GrantRestricted Stock Units · Derivative 60,600 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-021133 · ownership.xml · derivative · entry 1

Wei Binxian · CIK 0001773586 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,600

Underlying: Common Stock · 60,600 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan (the "Plan") to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash.

F2 · shares: This amended Form 4 is being filed to correct the previously reported grant amount of 510,700 RSUs to the Reporting Person. The Issuer has rescinded the grant of 450,100 RSUs of the previously reported grant of 510,700 RSUs.

F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date.

F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date.

Read SEC document
September 04, 2025 Filed Sep 5, 2025 13:00 UTC
Finley John DavidDirector · CEO, CFO
GrantPhantom Units · Derivative 323,400 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-012690 · ownership.xml · derivative · entry 1

Finley John David · CIK 0001851034 · Director · CEO, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 323,400

Underlying: Common Stock · 323,400 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: The Phantom Units vest in 12 equal quarterly installments beginning on November 5, 2025, subject to the Reporting Person's continuous service through each applicable vesting date.

F3 · derivative.exercise_date: Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service by the Issuer without Cause; (b) a Liquidity Change in Control of the Issuer; or (c) 7th anniversary of the grant date, in each case as such capitalized terms are defined in the Issuer's Phantom Unit Plan.

F2 · derivative.expiration_date: The Phantom Units vest in 12 equal quarterly installments beginning on November 5, 2025, subject to the Reporting Person's continuous service through each applicable vesting date.

F3 · derivative.expiration_date: Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service by the Issuer without Cause; (b) a Liquidity Change in Control of the Issuer; or (c) 7th anniversary of the grant date, in each case as such capitalized terms are defined in the Issuer's Phantom Unit Plan.

Read SEC document
September 04, 2025 Filed Sep 5, 2025 13:00 UTC GrantPhantom Units · Derivative 64,400 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-012693 · ownership.xml · derivative · entry 1

Williams Donald Allen · CIK 0001620013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,400

Underlying: Common Stock · 64,400 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date

F3 · derivative.exercise_date: Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date.

F2 · derivative.expiration_date: The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date

F3 · derivative.expiration_date: Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date.

Read SEC document
September 04, 2025 Filed Sep 5, 2025 13:00 UTC
Wei BinxianDirector
GrantPhantom Units · Derivative 18,800 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-012692 · ownership.xml · derivative · entry 1

Wei Binxian · CIK 0001773586 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,800

Underlying: Common Stock · 18,800 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.

F3 · derivative.exercise_date: Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date.

F2 · derivative.expiration_date: The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.

F3 · derivative.expiration_date: Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date.

Read SEC document
September 04, 2025 Filed Sep 5, 2025 13:00 UTC
Jones Mitchell LawrenceChief Medical Officer
GrantPhantom Units · Derivative 289,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-012691 · ownership.xml · derivative · entry 1

Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 289,000

Underlying: Common Stock · 289,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: The Phantom Units vest in 12 equal quarterly installments beginning on November 5, 2025, subject to the Reporting Person's continuous service through each applicable vesting date.

F3 · derivative.exercise_date: Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service by the Issuer without Cause; (b) a Liquidity Change in Control of the Issuer; or (c) 7th anniversary of the grant date, in each case as such capitalized terms are defined in the Issuer's Phantom Unit Plan.

F2 · derivative.expiration_date: The Phantom Units vest in 12 equal quarterly installments beginning on November 5, 2025, subject to the Reporting Person's continuous service through each applicable vesting date.

F3 · derivative.expiration_date: Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service by the Issuer without Cause; (b) a Liquidity Change in Control of the Issuer; or (c) 7th anniversary of the grant date, in each case as such capitalized terms are defined in the Issuer's Phantom Unit Plan.

Read SEC document
September 04, 2025 Filed Sep 5, 2025 13:00 UTC
Chuang EmilDirector
GrantPhantom Units · Derivative 18,800 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-012689 · ownership.xml · derivative · entry 1

Chuang Emil · CIK 0001921045 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,800

Underlying: Common Stock · 18,800 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.

F3 · derivative.exercise_date: Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date.

F2 · derivative.expiration_date: The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.

F3 · derivative.expiration_date: Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date.

Read SEC document
July 18, 2025 Filed Jul 22, 2025 20:22 UTC
Chuang EmilDirector
GrantStock Option (Right to Buy) · Derivative 8,000 $0.00 Strike: $0.75 $0.00
Disclosure

SEC source: 0001641172-25-020579 · ownership.xml · derivative · entry 1

Chuang Emil · CIK 0001921045 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires 2035-07-18

F1 · derivative.exercise_date: The option shall vest with respect to 8.33% of the underlying shares subject to the option in equal quarterly installments such that the option shall be fully vested on the three-year anniversary of July 18, 2025, subject to the reporting person's continued service as a member of the Issuer's Board of Directors through each applicable vesting date.

Read SEC document
February 11, 2025 Filed Feb 13, 2025 22:56 UTC
Finley John DavidDirector · CEO, CFO
GrantRestricted Stock Units · Derivative 40,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-006498 · ownership.xml · derivative · entry 2

Finley John David · CIK 0001851034 · Director · CEO, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service through each such vesting date.

F3 · derivative.expiration_date: The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service through each such vesting date.

Read SEC document
February 11, 2025 Filed Feb 13, 2025 22:56 UTC
Finley John DavidDirector · CEO, CFO
GrantStock Option (Right to Buy) · Derivative 47,000 $0.00 Strike: $1.13 $0.00
Disclosure

SEC source: 0001493152-25-006498 · ownership.xml · derivative · entry 1

Finley John David · CIK 0001851034 · Director · CEO, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,000

Underlying: Common Stock · 47,000 shares

Expires 2035-02-11

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in twelve equal quarterly installments over a three-year period beginning on May 11, 2025, subject to the Reporting Person's continuous service through each such vesting date.

Read SEC document
February 11, 2025 Filed Feb 13, 2025 22:58 UTC
Jones Mitchell LawrenceChief Medical Officer
GrantRestricted Stock Units · Derivative 24,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-006500 · ownership.xml · derivative · entry 2

Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.

F3 · derivative.expiration_date: The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.

Read SEC document
February 11, 2025 Filed Feb 13, 2025 22:58 UTC
Jones Mitchell LawrenceChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 29,000 $0.00 Strike: $1.13 $0.00
Disclosure

SEC source: 0001493152-25-006500 · ownership.xml · derivative · entry 1

Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,000

Underlying: Common Stock · 29,000 shares

Expires 2035-02-11

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in twelve equal quarterly installments over a three-year period with vesting commencing on May 11, 2025, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.

Read SEC document
November 21, 2024 Filed Nov 22, 2024 21:00 UTC Exercise / conversionComon Stock, par value $0.01 388 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-047363 · ownership.xml · nonDerivative · entry 1

Williams Donald Allen · CIK 0001620013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 728

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the issuance of common stock upon the full vesting and settlement of outstanding restricted stock units granted on November 21, 2023.

F1 · price: Represents the issuance of common stock upon the full vesting and settlement of outstanding restricted stock units granted on November 21, 2023.

Read SEC document
November 21, 2024 Filed Nov 22, 2024 21:00 UTC
Wei BinxianDirector
Exercise / conversionComon Stock, par value $0.01 388 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-047364 · ownership.xml · nonDerivative · entry 1

Wei Binxian · CIK 0001773586 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 855

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the issuance of common stock upon the full vesting and settlement of outstanding restricted stock units granted on November 21, 2023.

F1 · price: Represents the issuance of common stock upon the full vesting and settlement of outstanding restricted stock units granted on November 21, 2023.

Read SEC document
July 11, 2024 Filed Jul 16, 2024 00:19 UTC
Wei BinxianDirector
GrantCommon Stock Options · Derivative 2,100 $0.00 Strike: $4.49 $0.00
Disclosure

SEC source: 0001493152-24-027911 · ownership.xml · derivative · entry 1

Wei Binxian · CIK 0001773586 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,100

Underlying: Common Stock · 2,100 shares

Expires 2034-07-11

F1 · security: Represents partial compensation for services as a director pursuant to Issuer's non-employee director compensation policy, consisting of 2,100 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan.

F2 · security: The grants vest fully on the one (1) year anniversary of the grant date.

F3 · security: Each option represents the right to purchase one share of common stock at the exercise price.

F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date.

Read SEC document
July 11, 2024 Filed Jul 16, 2024 00:13 UTC GrantCommon Stock Options · Derivative 2,100 $0.00 Strike: $4.49 $0.00
Disclosure

SEC source: 0001493152-24-027909 · ownership.xml · derivative · entry 1

Fischbein Margery B. · CIK 0001766438 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,100

Underlying: Common Stock · 2,100 shares

Expires 2034-07-11

F1 · security: Represents partial compensation for services as a director pursuant to Issuer's non-employee director compensation policy, consisting of 2,100 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan.

F2 · security: The grants vest fully on the one (1) year anniversary of the grant date.

F3 · security: Each option represents the right to purchase one share of common stock at the exercise price.

F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date.

Read SEC document
July 11, 2024 Filed Jul 16, 2024 00:10 UTC GrantCommon Stock Options · Derivative 2,100 $0.00 Strike: $4.49 $0.00
Disclosure

SEC source: 0001493152-24-027907 · ownership.xml · derivative · entry 1

Williams Donald Allen · CIK 0001620013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,100

Underlying: Common Stock · 2,100 shares

Expires 2034-07-11

F1 · security: Represents partial compensation for services as a director pursuant to Issuer's non-employee director compensation policy, consisting of 2,100 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan.

F2 · security: The grants vest fully on the one (1) year anniversary of the grant date.

F3 · security: Each option represents the right to purchase one share of common stock at the exercise price.

F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date.

Read SEC document
June 11, 2024 Filed Jun 13, 2024 01:41 UTC
Wei BinxianDirector
Exercise / conversionComon Stock, par value $0.01 465 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-023614 · ownership.xml · nonDerivative · entry 1

Wei Binxian · CIK 0001773586 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 467

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023.

F1 · shares: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023.

F1 · price: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023.

Read SEC document
June 11, 2024 Filed Jun 13, 2024 01:40 UTC Exercise / conversionComon Stock, par value $0.01 340 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-023612 · ownership.xml · nonDerivative · entry 1

Williams Donald Allen · CIK 0001620013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 340

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023.

F1 · shares: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023.

F1 · price: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023.

Read SEC document
May 28, 2024 Filed May 29, 2024 19:47 UTC PurchaseComon Stock, par value $0.01 1,000 $4.86 $4,863.00
Disclosure

SEC source: 0001493152-24-021777 · ownership.xml · nonDerivative · entry 1

Williams Donald Allen · CIK 0001620013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000

F1 · shares: Reporting Person purchased 1,000 shares of Common Stock of Issuer at a price per share of $4.863 on May 28, 2024.

Read SEC document
May 28, 2024 Filed May 30, 2024 23:44 UTC
Finley John DavidDirector · CEO, CFO, Director
Exercise / conversionRestricted Stock Units · Derivative 2,111 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-24-022037 · ownership.xml · derivative · entry 10

Finley John David · CIK 0001851034 · Director · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,111 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F11 · security: This restricted stock unit was granted on November 21, 2023, and all remaining 2,111 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer.

F11 · derivative.exercise_price: This restricted stock unit was granted on November 21, 2023, and all remaining 2,111 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer.

F11 · price: This restricted stock unit was granted on November 21, 2023, and all remaining 2,111 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer.

F8 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

F8 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Read SEC document
May 28, 2024 Filed May 30, 2024 23:44 UTC
Finley John DavidDirector · CEO, CFO, Director
Exercise / conversionRestricted Stock Units · Derivative 3,335 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-24-022037 · ownership.xml · derivative · entry 9

Finley John David · CIK 0001851034 · Director · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,335 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · security: This restricted stock unit was granted on June 11, 2023, and all remaining 3,335 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer.

F10 · derivative.exercise_price: This restricted stock unit was granted on June 11, 2023, and all remaining 3,335 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer.

F10 · price: This restricted stock unit was granted on June 11, 2023, and all remaining 3,335 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer.

F8 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

F8 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Read SEC document
May 28, 2024 Filed May 30, 2024 23:44 UTC
Finley John DavidDirector · CEO, CFO, Director
Exercise / conversionRestricted Stock Units · Derivative 1,622 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-24-022037 · ownership.xml · derivative · entry 8

Finley John David · CIK 0001851034 · Director · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,622 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · security: This restricted stock unit was granted on June 8, 2023, and all remaining 1,622 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer.

F9 · derivative.exercise_price: This restricted stock unit was granted on June 8, 2023, and all remaining 1,622 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer.

F9 · price: This restricted stock unit was granted on June 8, 2023, and all remaining 1,622 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer.

F8 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

F8 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Read SEC document
May 28, 2024 Filed May 30, 2024 23:44 UTC
Finley John DavidDirector · CEO, CFO, Director
Tax withholdingCommon Stock, par value $0.01 607 $4.76 $2,889.32
Disclosure

SEC source: 0001493152-24-022037 · ownership.xml · nonDerivative · entry 6

Finley John David · CIK 0001851034 · Director · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,472

F6 · security: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 5.

F6 · shares: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 5.

Read SEC document
May 28, 2024 Filed May 30, 2024 23:44 UTC
Finley John DavidDirector · CEO, CFO, Director
Exercise / conversionCommon Stock, par value $0.01 2,111 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-022037 · ownership.xml · nonDerivative · entry 5

Finley John David · CIK 0001851034 · Director · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,079

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023.

F5 · shares: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023.

F5 · price: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023.

Read SEC document
May 28, 2024 Filed May 30, 2024 23:44 UTC
Finley John DavidDirector · CEO, CFO, Director
Tax withholdingCommon Stock, par value $0.01 959 $4.76 $4,564.84
Disclosure

SEC source: 0001493152-24-022037 · ownership.xml · nonDerivative · entry 4

Finley John David · CIK 0001851034 · Director · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,968

F4 · security: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3.

F4 · shares: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3.

Read SEC document
May 28, 2024 Filed May 30, 2024 23:44 UTC
Finley John DavidDirector · CEO, CFO, Director
Exercise / conversionCommon Stock, par value $0.01 3,335 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-022037 · ownership.xml · nonDerivative · entry 3

Finley John David · CIK 0001851034 · Director · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,927

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023.

F3 · shares: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023.

F3 · price: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023.

Read SEC document
May 28, 2024 Filed May 30, 2024 23:44 UTC
Finley John DavidDirector · CEO, CFO, Director
Tax withholdingCommon Stock, par value $0.01 467 $4.76 $2,222.92
Disclosure

SEC source: 0001493152-24-022037 · ownership.xml · nonDerivative · entry 2

Finley John David · CIK 0001851034 · Director · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,592

F2 · security: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1.

F2 · shares: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1.

Read SEC document
May 28, 2024 Filed May 30, 2024 23:44 UTC
Finley John DavidDirector · CEO, CFO, Director
Exercise / conversionCommon Stock, par value $0.01 1,622 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-022037 · ownership.xml · nonDerivative · entry 1

Finley John David · CIK 0001851034 · Director · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,059

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 8, 2023.

F1 · shares: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 8, 2023.

F1 · price: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 8, 2023.

Read SEC document
May 28, 2024 Filed May 30, 2024 23:44 UTC
Jones Mitchell LawrenceChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 1,555 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-24-022038 · ownership.xml · derivative · entry 6

Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,555 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · security: This restricted stock unit was granted on November 21 2024, and all remaining 1,555 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer.

F7 · derivative.exercise_price: This restricted stock unit was granted on November 21 2024, and all remaining 1,555 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer.

F7 · price: This restricted stock unit was granted on November 21 2024, and all remaining 1,555 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer.

F5 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

F5 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Read SEC document
May 28, 2024 Filed May 30, 2024 23:44 UTC
Jones Mitchell LawrenceChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 2,735 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-24-022038 · ownership.xml · derivative · entry 5

Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,735 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: This restricted stock unit was granted on September 5, 2023, and all remaining 2,735 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer.

F6 · derivative.exercise_price: This restricted stock unit was granted on September 5, 2023, and all remaining 2,735 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer.

F6 · price: This restricted stock unit was granted on September 5, 2023, and all remaining 2,735 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer.

F5 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

F5 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Read SEC document
May 28, 2024 Filed May 30, 2024 23:44 UTC
Jones Mitchell LawrenceChief Medical Officer
Tax withholdingCommon Stock, par value $0.01 461 $4.76 $2,194.36
Disclosure

SEC source: 0001493152-24-022038 · ownership.xml · nonDerivative · entry 4

Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,852

F4 · security: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3.

F4 · shares: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3.

Read SEC document
May 28, 2024 Filed May 30, 2024 23:44 UTC
Jones Mitchell LawrenceChief Medical Officer
Exercise / conversionCommon Stock, par value $0.01 1,555 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-022038 · ownership.xml · nonDerivative · entry 3

Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,313

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023.

F3 · shares: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023.

F3 · price: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023.

Read SEC document
May 28, 2024 Filed May 30, 2024 23:44 UTC
Jones Mitchell LawrenceChief Medical Officer
Tax withholdingCommon Stock, par value $0.01 810 $4.76 $3,855.60
Disclosure

SEC source: 0001493152-24-022038 · ownership.xml · nonDerivative · entry 2

Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,758

F2 · security: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1.

F2 · shares: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1.

Read SEC document
May 28, 2024 Filed May 30, 2024 23:44 UTC
Jones Mitchell LawrenceChief Medical Officer
Exercise / conversionCommon Stock, par value $0.01 2,735 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-022038 · ownership.xml · nonDerivative · entry 1

Jones Mitchell Lawrence · CIK 0001993292 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,568

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023.

F1 · shares: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023.

F1 · price: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023.

Read SEC document
May 24, 2024 Filed May 28, 2024 10:02 UTC
Finley John DavidDirector · CEO, CFO, Director
PurchaseCommon Stock, par value $0.01 1,000 $4.81 $4,810.00
Disclosure

SEC source: 0001493152-24-021431 · ownership.xml · nonDerivative · entry 1

Finley John David · CIK 0001851034 · Director · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,437

F1 · security: Reporting Person purchased 1,000 shares of Common Stock of Issuer at a price per share of $4.81 on May 24, 2024.

F1 · shares: Reporting Person purchased 1,000 shares of Common Stock of Issuer at a price per share of $4.81 on May 24, 2024.

F1 · price: Reporting Person purchased 1,000 shares of Common Stock of Issuer at a price per share of $4.81 on May 24, 2024.

Read SEC document
May 20, 2024 Filed May 22, 2024 20:52 UTC
Finley John DavidDirector · CEO, CFO, Director
GrantCommon Stock, par value $0.01 666 $4.97 $3,311.69
Disclosure

SEC source: 0001493152-24-021045 · ownership.xml · nonDerivative · entry 1

Finley John David · CIK 0001851034 · Director · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,437

F1 · security: Shares were purchased pursuant to the Palisade Bio, Inc. 2021 Employee Stock Purchase Plan, as amended ("ESPP") for the ESPP purchase period from November 21, 2023 through May 20, 2024. In accordance with the ESPP, the shares were purchased in a transaction exempt under Rule 16b-3(c) at a price equal to 85% of the closing price of the issuer's common stock on May 20, 2024.

F1 · shares: Shares were purchased pursuant to the Palisade Bio, Inc. 2021 Employee Stock Purchase Plan, as amended ("ESPP") for the ESPP purchase period from November 21, 2023 through May 20, 2024. In accordance with the ESPP, the shares were purchased in a transaction exempt under Rule 16b-3(c) at a price equal to 85% of the closing price of the issuer's common stock on May 20, 2024.

F1 · price: Shares were purchased pursuant to the Palisade Bio, Inc. 2021 Employee Stock Purchase Plan, as amended ("ESPP") for the ESPP purchase period from November 21, 2023 through May 20, 2024. In accordance with the ESPP, the shares were purchased in a transaction exempt under Rule 16b-3(c) at a price equal to 85% of the closing price of the issuer's common stock on May 20, 2024.

Read SEC document
May 06, 2024 Filed May 8, 2024 22:36 UTC
Finley John DavidDirector · CEO, CFO, Director
Exercise / conversionRestricted Stock Units · Derivative 211 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-24-018282 · ownership.xml · derivative · entry 7

Finley John David · CIK 0001851034 · Director · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,111

Underlying: Common Stock · 211 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · security: This restricted stock unit was granted on November 21, 2023, and 211 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,111 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.

F8 · derivative.exercise_price: This restricted stock unit was granted on November 21, 2023, and 211 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,111 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.

F8 · price: This restricted stock unit was granted on November 21, 2023, and 211 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,111 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.

F6 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

F6 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Read SEC document
May 06, 2024 Filed May 8, 2024 22:36 UTC
Finley John DavidDirector · CEO, CFO, Director
Exercise / conversionRestricted Stock Units · Derivative 232 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-24-018282 · ownership.xml · derivative · entry 6

Finley John David · CIK 0001851034 · Director · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,622

Underlying: Common Stock · 232 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · security: This restricted stock unit was granted on June 8, 2023, and 232 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,622 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.

F7 · derivative.exercise_price: This restricted stock unit was granted on June 8, 2023, and 232 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,622 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.

F7 · price: This restricted stock unit was granted on June 8, 2023, and 232 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,622 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.

F6 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

F6 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Read SEC document
May 06, 2024 Filed May 8, 2024 22:36 UTC
Finley John DavidDirector · CEO, CFO, Director
Tax withholdingCommon Stock, par value $0.01 61 $8.46 $516.06
Disclosure

SEC source: 0001493152-24-018282 · ownership.xml · nonDerivative · entry 4

Finley John David · CIK 0001851034 · Director · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,771

F4 · security: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3.

F4 · shares: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3.

Read SEC document
May 06, 2024 Filed May 8, 2024 22:36 UTC
Finley John DavidDirector · CEO, CFO, Director
Exercise / conversionCommon Stock, par value $0.01 211 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-018282 · ownership.xml · nonDerivative · entry 3

Finley John David · CIK 0001851034 · Director · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,832

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023.

F3 · shares: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023.

F3 · price: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023.

Read SEC document
May 06, 2024 Filed May 8, 2024 22:36 UTC
Finley John DavidDirector · CEO, CFO, Director
Tax withholdingCommon Stock, par value $0.01 67 $8.46 $566.82
Disclosure

SEC source: 0001493152-24-018282 · ownership.xml · nonDerivative · entry 2

Finley John David · CIK 0001851034 · Director · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,621

F2 · security: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1.

F2 · shares: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1.

Read SEC document
May 06, 2024 Filed May 8, 2024 22:36 UTC
Finley John DavidDirector · CEO, CFO, Director
Exercise / conversionCommon Stock, par value $0.01 232 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-018282 · ownership.xml · nonDerivative · entry 1

Finley John David · CIK 0001851034 · Director · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,688

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 8, 2023.

F1 · shares: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 8, 2023.

F1 · price: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 8, 2023.

Read SEC document
May 06, 2024 Filed May 8, 2024 22:37 UTC
Jones Mitchell LawrenceCEO, CFO, Director
Exercise / conversionRestricted Stock Units · Derivative 156 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-24-018284 · ownership.xml · derivative · entry 6

Jones Mitchell Lawrence · CIK 0001993292 · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,555

Underlying: Common Stock · 156 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · security: This restricted stock unit was granted on November 21, 2023, and 156 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,555 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.

F7 · derivative.exercise_price: This restricted stock unit was granted on November 21, 2023, and 156 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,555 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.

F7 · price: This restricted stock unit was granted on November 21, 2023, and 156 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,555 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.

F5 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

F5 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Read SEC document
May 06, 2024 Filed May 8, 2024 22:37 UTC
Jones Mitchell LawrenceCEO, CFO, Director
Exercise / conversionRestricted Stock Units · Derivative 304 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-24-018284 · ownership.xml · derivative · entry 5

Jones Mitchell Lawrence · CIK 0001993292 · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,735

Underlying: Common Stock · 304 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: This restricted stock unit was granted on September 5, 2023, and 304 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,735 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.

F6 · derivative.exercise_price: This restricted stock unit was granted on September 5, 2023, and 304 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,735 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.

F6 · price: This restricted stock unit was granted on September 5, 2023, and 304 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,735 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.

F5 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

F5 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Read SEC document
May 06, 2024 Filed May 8, 2024 22:37 UTC
Jones Mitchell LawrenceCEO, CFO, Director
Tax withholdingCommon Stock, par value $0.01 47 $8.46 $397.62
Disclosure

SEC source: 0001493152-24-018284 · ownership.xml · nonDerivative · entry 4

Jones Mitchell Lawrence · CIK 0001993292 · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 833

F4 · security: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3.

F4 · shares: Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3.

Read SEC document
May 06, 2024 Filed May 8, 2024 22:37 UTC
Jones Mitchell LawrenceCEO, CFO, Director
Exercise / conversionCommon Stock, par value $0.01 156 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-018284 · ownership.xml · nonDerivative · entry 3

Jones Mitchell Lawrence · CIK 0001993292 · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 880

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023.

F3 · shares: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023.

F3 · price: Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.